208 related articles for article (PubMed ID: 17919174)
1. Unexpected functional consequences of xenogeneic transgene expression in beta-cells of NOD mice.
Leiter EH; Reifsnyder P; Driver J; Kamdar S; Choisy-Rossi C; Serreze DV; Hara M; Chervonsky A
Diabetes Obes Metab; 2007 Nov; 9 Suppl 2():14-22. PubMed ID: 17919174
[TBL] [Abstract][Full Text] [Related]
2. Beta cell-specific ablation of target gene using Cre-loxP system in transgenic mice.
Ray MK; Fagan SP; Moldovan S; DeMayo FJ; Brunicardi FC
J Surg Res; 1999 Jun; 84(2):199-203. PubMed ID: 10357920
[TBL] [Abstract][Full Text] [Related]
3. Prevention of insulin-dependent diabetes mellitus in non-obese diabetic mice by transgenes encoding modified I-A beta-chain or normal I-E alpha-chain.
Lund T; O'Reilly L; Hutchings P; Kanagawa O; Simpson E; Gravely R; Chandler P; Dyson J; Picard JK; Edwards A
Nature; 1990 Jun; 345(6277):727-9. PubMed ID: 2163026
[TBL] [Abstract][Full Text] [Related]
4. Alterations of pancreatic beta-cell mass and islet number due to Ins2-controlled expression of Cre recombinase: RIP-Cre revisited; part 2.
Pomplun D; Florian S; Schulz T; Pfeiffer AF; Ristow M
Horm Metab Res; 2007 May; 39(5):336-40. PubMed ID: 17533574
[TBL] [Abstract][Full Text] [Related]
5. A mouse model for beta cell-specific ablation of target gene(s) using the Cre-loxP system.
Ray MK; Fagan SP; Moldovan S; DeMayo FJ; Brunicardi FC
Biochem Biophys Res Commun; 1998 Dec; 253(1):65-9. PubMed ID: 9875221
[TBL] [Abstract][Full Text] [Related]
6. Transplantation of bone marrow genetically engineered to express proinsulin II protects against autoimmune insulitis in NOD mice.
Chan J; Clements W; Field J; Nasa Z; Lock P; Yap F; Toh BH; Alderuccio F
J Gene Med; 2006 Nov; 8(11):1281-90. PubMed ID: 16989008
[TBL] [Abstract][Full Text] [Related]
7. Adjuvant immunotherapy increases beta cell regenerative factor Reg2 in the pancreas of diabetic mice.
Huszarik K; Wright B; Keller C; Nikoopour E; Krougly O; Lee-Chan E; Qin HY; Cameron MJ; Gurr WK; Hill DJ; Sherwin RS; Kelvin DJ; Singh B
J Immunol; 2010 Nov; 185(9):5120-9. PubMed ID: 20876350
[TBL] [Abstract][Full Text] [Related]
8. Transgenic expression of single-chain anti-CTLA-4 Fv on beta cells protects nonobese diabetic mice from autoimmune diabetes.
Shieh SJ; Chou FC; Yu PN; Lin WC; Chang DM; Roffler SR; Sytwu HK
J Immunol; 2009 Aug; 183(4):2277-85. PubMed ID: 19635924
[TBL] [Abstract][Full Text] [Related]
9. Bridging mice to men: using HLA transgenic mice to enhance the future prediction and prevention of autoimmune type 1 diabetes in humans.
Serreze DV; Niens M; Kulik J; Dilorenzo TP
Methods Mol Biol; 2010; 602():119-34. PubMed ID: 20012396
[TBL] [Abstract][Full Text] [Related]
10. Targeted expression of the anti-apoptotic gene CrmA to NOD pancreatic islets protects from autoimmune diabetes.
Millet I; Wong FS; Gurr W; Wen L; Zawalich W; Green EA; Flavell RA; Sherwin RS
J Autoimmun; 2006 Feb; 26(1):7-15. PubMed ID: 16338119
[TBL] [Abstract][Full Text] [Related]
11. Experimental autoimmune diabetes: a new tool to study mechanisms and consequences of insulin-specific autoimmunity.
Rajasalu T; Barth C; Spyrantis A; Durinovic-Belló I; Uibo R; Schirmbeck R; Boehm BO; Karges W
Ann N Y Acad Sci; 2004 Dec; 1037():208-15. PubMed ID: 15699519
[TBL] [Abstract][Full Text] [Related]
12. Neural expression of alpha-internexin promoter in vitro and in vivo.
Wang P; Wang SM; Hsieh CJ; Chien CL
J Cell Biochem; 2006 Feb; 97(2):275-87. PubMed ID: 16173078
[TBL] [Abstract][Full Text] [Related]
13. "Humanized" HLA transgenic NOD mice to identify pancreatic beta cell autoantigens of potential clinical relevance to type 1 diabetes.
Serreze DV; Marron MP; Dilorenzo TP
Ann N Y Acad Sci; 2007 Apr; 1103():103-11. PubMed ID: 17376821
[TBL] [Abstract][Full Text] [Related]
14. Direct evidence for the contribution of the unique I-ANOD to the development of insulitis in non-obese diabetic mice.
Miyazaki T; Uno M; Uehira M; Kikutani H; Kishimoto T; Kimoto M; Nishimoto H; Miyazaki J; Yamamura K
Nature; 1990 Jun; 345(6277):722-4. PubMed ID: 2113614
[TBL] [Abstract][Full Text] [Related]
15. The natural history of insulin content in the pancreas of female and male non-obese diabetic mouse: implications for trials of diabetes prevention in humans.
Valorani MG; Hawa MI; Buckley LR; Afeltra A; Cacciapaglia F; Pozzilli P
Diabetes Metab Res Rev; 2004; 20(5):394-8. PubMed ID: 15343585
[TBL] [Abstract][Full Text] [Related]
16. Transgenic mice with green fluorescent protein-labeled pancreatic beta -cells.
Hara M; Wang X; Kawamura T; Bindokas VP; Dizon RF; Alcoser SY; Magnuson MA; Bell GI
Am J Physiol Endocrinol Metab; 2003 Jan; 284(1):E177-83. PubMed ID: 12388130
[TBL] [Abstract][Full Text] [Related]
17. Dynamic interaction between T cell-mediated beta-cell damage and beta-cell repair in the run up to autoimmune diabetes of the NOD mouse.
Vukkadapu SS; Belli JM; Ishii K; Jegga AG; Hutton JJ; Aronow BJ; Katz JD
Physiol Genomics; 2005 Apr; 21(2):201-11. PubMed ID: 15671250
[TBL] [Abstract][Full Text] [Related]
18. Caveats and considerations for performing pancreas-specific gene manipulations in the mouse.
Magnuson MA; Burlison JS
Diabetes Obes Metab; 2007 Nov; 9 Suppl 2():5-13. PubMed ID: 17919173
[TBL] [Abstract][Full Text] [Related]
19. Autoimmunity in HLA-DQ8 transgenic mice expressing granulocyte/macrophage-colony stimulating factor in the beta cells of islets of Langerhans.
Rajagopalan G; Mangalam AK; Sen MM; Cheng S; Kudva YC; David CS
Autoimmunity; 2007 May; 40(3):169-79. PubMed ID: 17453715
[TBL] [Abstract][Full Text] [Related]
20. Expression of IGF-I in pancreatic islets prevents lymphocytic infiltration and protects mice from type 1 diabetes.
Casellas A; Salavert A; Agudo J; Ayuso E; Jimenez V; Moya M; Muñoz S; Franckhauser S; Bosch F
Diabetes; 2006 Dec; 55(12):3246-55. PubMed ID: 17130467
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
